Postes actifs de Andrew Muratore
Sociétés | Poste | Début | Fin |
---|---|---|---|
TRILLIUM THERAPEUTICS | Directeur/Membre du Conseil | 17/11/2021 | - |
Corporate Officer/Principal | 17/11/2021 | - |
Historique de carrière de Andrew Muratore
Statistiques
Internationale
Canada | 2 |
Opérationnelle
Director/Board Member | 1 |
Corporate Officer/Principal | 1 |
Sectorielle
Health Technology | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Entreprise privées | 1 |
---|---|
Trillium Therapeutics ULC
Trillium Therapeutics ULC BiotechnologyHealth Technology Trillium Therapeutics, Inc. is a clinical stage immuno-oncology company, which engages in the research and development of therapies for the treatment of cancer. It offers clinical programs, TTI-621 and TTI-622, target CD47, a signal that cancer cells frequently use to evade the immune system. The company was founded on March 31, 2004 and is headquartered in Mississauga, Canada. | Health Technology |
- Bourse
- Insiders
- Andrew Muratore
- Expérience